Table 5.
CMR data for early reperfused versus non-reperfused patients
| Variable | Early reperfused (n = 59) | Non-reperfused (n = 21) | p |
|---|---|---|---|
| Age (y) |
60.2 ± 11.9 |
65.6 ± 16.2 |
0.11 |
| Male sex (%) |
53 (89.8) |
16 (76.2) |
0.12 |
| Time admission-CMR (d) |
1.9 (1.2-2.6) |
6.6 (4.8-11.0) |
<0.001 |
| LVEDVI (ml/m2) |
90.7 (82.4-102.7) |
98.0 (88.1-125.0) |
0.005 |
| LVESVI (ml/m2) |
51.4 (45.4-62.6) |
61.1 (54.0-83.6) |
0.002 |
| EF (%) |
42.3 ± 7.8 |
35.0 ± 11.3 |
0.002 |
| IS (%LVM) |
24.4 ± 15.3 |
23.8 ± 11.5 |
0.87 |
| MVO prevalence (n,%) |
33 (55.9%) |
15 (71.4%) |
0.21 |
| MVO (%LVM) | 0.4 (0.0-2.9) | 1.3 (0.0-2.8) | 0.36 |
PPCI = primary percutaneous coronary angioplasty, LVEDVI = left ventricular end-diastolic volume-index, LVESVI = left ventricular end-systolic volume-index, LVEDMI = left ventricular end-diastolic mass, LVEF = left ventricular ejection fraction, IS = infarct size (%LV mass), MVO = microvascular obstruction (%LV mass).